GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Clinical trials for GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot gene therapy aims to halt blinding eye disease
Disease control Recruiting nowThis early-stage study is testing a new, one-time gene therapy injection for people with geographic atrophy, an advanced form of age-related macular degeneration that causes permanent vision loss. The goal is to see if the treatment is safe and if it can slow or stop the growth o…
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 05:57 UTC
-
New shot aims to halt blinding eye disease
Disease control Recruiting nowThis study is testing if a new medicine called ADX-038, given as an injection under the skin, can slow down the progression of geographic atrophy. Geographic atrophy is a severe form of age-related macular degeneration that causes permanent blind spots in central vision. The tria…
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo aims to halt blinding eye disease
Disease control Recruiting nowThis study is testing whether adding a new investigational drug called APL-3007 to an existing treatment (Syfovre) can better slow the progression of geographic atrophy, a late-stage form of age-related macular degeneration that causes permanent vision loss. About 240 participant…
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
One-Shot eye injection aims to halt blinding disease
Disease control Recruiting nowThis study is testing a new, one-time injection called CTx001 for people with geographic atrophy, a severe form of age-related macular degeneration that causes permanent vision loss. The main goals are to see if the injection is safe and if it can slow down the damage to the reti…
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Complement Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Zapping eyes with tiny currents to fight vision loss
Disease control Recruiting nowThis study is testing whether a gentle electrical current applied near the eye can help slow vision loss from dry age-related macular degeneration (AMD). About 100 participants with intermediate to advanced dry AMD will use the device at home for 11 months, with some receiving a …
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: i-Lumen Scientific AUS PTY LTD • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New eye injection trial aims to slow blinding disease
Disease control Recruiting nowThis study is testing different doses of an investigational eye injection called FWY003 to see if it can slow the progression of geographic atrophy, a late-stage form of age-related macular degeneration that causes permanent vision loss. About 272 participants aged 50+ with this …
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists watch closely as eye disease steals sight
Knowledge-focused Recruiting nowThis is an observational study that aims to learn more about how quickly geographic atrophy, a form of age-related macular degeneration that causes permanent vision loss, gets worse over a short period. It will enroll about 75 people aged 55 and older who have this condition in b…
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Sponsor: Complement Therapeutics • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC